CONFIDENTIAL TREATMENT MANUFACTURING AND SUPPLY AGREEMENTConfidential Treatment • June 6th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Manufacturing and Supply Agreement (Agreement) is entered into as of September 30, 2001 (Effective Date) by and between ACS Dobfar, SpA, an Italian corporation (ACSD) and Cubist Pharmaceuticals, Inc., a Delaware corporation (Cubist).
CONFIDENTIAL TREATMENT FIRST AMENDMENTConfidential Treatment • June 6th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment is dated 4th February 2002, and is made between Cubist Pharmaceuticals, Inc. (“Cubist”), a Delaware corporation having its principal place of business at 65 Hayden Avenue, Lexington, Massachusetts 02421, U.S.A., and Novartis Pharma AG (“Novartis”), a Swiss corporation having its principal place of business at Lichtstrasse 35, CH-4002 Basel, Switzerland,.
CONFIDENTIAL TREATMENT SCREENING SERVICE AGREEMENTScreening Service Agreement • June 6th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Screening Service Agreement (“Agreement”) dated as of December 7, 2001 (the “Effective Date”) is between Cetek Corporation (hereinafter “Cetek”) having a place of business at 260 Cedar Hill Street, Marlborough, Massachusetts, 01752 and Cubist Pharmaceuticals, Inc. (hereinafter “Cubist”) having a place of business at 65 Hayden Ave., Lexington, Massachusetts, 02421.
CONFIDENTIAL TREATMENT LICENSE AGREEMENT dated December 27, 2001 between CUBIST PHARMACEUTICALS, INC. and UNIVERSITY OF UTAH RESEARCH FOUNDATIONLicense Agreement • June 6th, 2003 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Utah
THIS LICENSE AGREEMENT (“AGREEMENT”) is entered into this 27th day of December, 2001 (the “Effective Date”) by and between the UNIVERSITY OF UTAH RESEARCH FOUNDATION, a Utah non-profit corporation, having its principal place of business at 615 Arapeen Drive, Suite 110, Salt Lake City, UT 84108, hereinafter referred to as “UNIVERSITY,” and CUBIST PHARMACEUTICALS, INC., having its principal place of business at 65 Hayden Avenue, Lexington, MA 02421, hereinafter referred to as “CUBIST.”
